* ATLANTIC BONE SCREEN *
2005 - Bretagne
Nantes
www.atlantic-bone-screen.com Contract, Services
Key words: Validation, In-vivo testing, Osteo-articular pathologies, LPRO
Mission: to offer in vitro and in vivo (patented animal models) services dedicated to validation of proof of concept in osteoarticular pathologies, and (Atlanchim) to act as a subcontractor for the synthesis of new molecules
Clients: Pharmaceutical industry, Biotechs, Chemical industry, Food industry
contact@atlantic-bone-screen.com
Age: 6 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Personal venture |
Managing Dir.-CEO: Le Bot (Ronan) [co-founder, born 1977, Pharm.D.]
Sc.Dir.-CSO:
Fin.Dir.-CFO:
BusDev: Porcher (Elisabeth) [MBA, ex-Eurocopter]
Financers (Hist.): privately owned (registered capital 2006 = 0.04 M€), internal growth (no outside investors searched) | Turnover (M€) : 0.36 (2009), 0.14 (2008), 0.012 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Inflammation
Position : Subcontractor
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2008 .05 | Acquisition of Atlanchim, molecular chemical synthesis subcontractor (at book value, plus 5 maintained jobs) | ACQ+ | [2 years] |
| 2005 .11 | Company founded by Ronan Le Bot, Dr Dominique Heymann, Dr Françoise Redini, Dr Marc Padrines, Dr Yannick Fortun, and Prof. François Gouin | ORGF | [0 year] | Actualisation / Updating: 3-May-2011 |
|
